Rachel E. Haurwitz, President and CEO at Caribou Biosciences, Inc. (CRBU), bought 20,000 shares at $1.02 ($20K) on 2025-03-14, disclosed to the SEC on 2025-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.